If There Is Loss to Follow Up, Poor Outcomes May Be More Common after Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Retinopathy

Schachat Andrew P.

首页> 外文期刊>Ophthalmology >If There Is Loss to Follow Up, Poor Outcomes May Be More Common after Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Retinopathy

【24h】

If There Is Loss to Follow Up, Poor Outcomes May Be More Common after Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Retinopathy

机译：如果失去跟进，患有糖尿病视网膜病变的抗血管内皮生长因子治疗后可能更常见的结果

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Ophthalmology》 |2019年第3期|共1页
作者
Schachat Andrew P.;
展开▼
作者单位

Cleveland Clin Cole Eye Inst 9500 Euclid Ave I-30 Cleveland OH 44195 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. If There Is Loss to Follow Up, Poor Outcomes May Be More Common after Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Retinopathy [J] . Schachat Andrew P. Ophthalmology . 2019,第3期

机译：如果失去跟进，患有糖尿病视网膜病变的抗血管内皮生长因子治疗后可能更常见的结果
2. Outcomes in proliferative diabetic retinopathy patients who are lost to follow-up after panretinal photocoagulation vs. intravitreal anti-vascular endothelial growth factor injection [J] . Hsu Jason, Obeid Anthony, Su Daniel, Investigative ophthalmology & visual science . 2018,第9期

机译：增殖性糖尿病视网膜病变患者的结果在Panretinal光凝术后失去后续患者与玻璃体抗体抗血管内皮生长因子注射液
3. Vascular endothelial growth factor gene polymorphism prevalence in patients with diabetic macular oedema and its correlation with anti-vascular endothelial growth factor treatment outcomes [J] . El-ShazlyS.F., El-BradeyM.H., TameeshM.K. Clinical and experimental ophthalmology . 2014,第4期

机译：糖尿病性黄斑水肿患者血管内皮生长因子基因多态性患病率及其与抗血管内皮生长因子治疗结果的相关性
4. Vascular Endothelial Growth Factor and the Potential Therapeutic Use of Pegaptanib (Macugen ) in Diabetic Retinopathy [C] . Carla Starita, Manju Patel, Barrett Katz, International Consortium for Medical Care of Hibakusha and Radiation Life Science . 2007

机译：血管内皮生长因子及Pegaptanib（Macugen）在糖尿病视网膜病变中的潜在治疗用途
5. The role of endothelial cell injury and repair in diabetic retinopathy. [D] . Tikhonenko, Maria. 2012

机译：内皮细胞损伤和修复在糖尿病性视网膜病中的作用。
6. Anti-vascular Endothelial Growth Factor Treatment of Retinopathy of Prematurity: Efficacy Safety and Anatomical Outcomes [O] . Hyun Goo Kang, Eun Young Choi, Suk Ho Byeon, 2018

机译：抗血管内皮生长因子治疗早产儿视网膜病变的功效安全性和解剖学结果
7. If There Is Loss to Follow Up, Poor Outcomes May Be More Common after Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Retinopathy [O] . Andrew P. Schachat 2019

机译：如果失去跟进，患有糖尿病视网膜病变的抗血管内皮生长因子治疗后可能更常见的结果

If There Is Loss to Follow Up, Poor Outcomes May Be More Common after Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Retinopathy

著录项

引文网络

相似文献

相关主题

期刊订阅